Phio Pharmaceuticals(PHIO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PHIO Phio Pharmaceuticals

盘前交易 07-18 07:27:22 EDT

4.72

+0.17

+3.66%

最高5.08	最低4.39	成交量7.96万
今开4.59	昨收4.55	日振幅15.20%
总市值240.64万	流通市值238.81万	总股本51.02万
成交额37.48万	换手率15.73%	流通股本50.63万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"PHIO","market":"US","secType":"STK","nameCN":"Phio Pharmaceuticals","latestPrice":4.7166,"timestamp":1721246400000,"preClose":4.55,"halted":0,"volume":79639,"delay":0,"floatShares":506318,"shares":510188,"eps":-28.686651,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.1666,"latestTime":"07-18 07:27:22 EDT","open":4.59,"high":5.0815,"low":4.39,"amount":374784.080643,"amplitude":0.151978,"askPrice":6.62,"askSize":100,"bidPrice":4.32,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-28.686651,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721309400000},"adr":0,"adjPreClose":4.7,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":4.6,"preClose":4.7166,"latestTime":"19:58 EDT","volume":1003,"amount":4642.96,"timestamp":1721260702523},"volumeRatio":4.197620578211964,"impliedVol":2.2675,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/PHIO","defaultTab":"news","newsList":[{"id":"2452195829","title":"Phio Pharmaceuticals Corp.盘中异动 股价大涨5.05%报4.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452195829","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452195829?lang=zh_cn&edition=full","pubTime":"2024-07-18 02:13","pubTimestamp":1721239998,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日02时13分，Phio Pharmaceuticals Corp.股票出现异动，股价大幅拉升5.05%。截至发稿，该股报4.78美元/股，成交量2.052万股，换手率4.02%，振幅8.35%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为1.71%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718021318941f7fa2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718021318941f7fa2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2451913822","title":"Phio Pharmaceuticals Corp.盘中异动 早盘快速跳水8.41%报4.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451913822","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451913822?lang=zh_cn&edition=full","pubTime":"2024-07-16 22:07","pubTimestamp":1721138862,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日22时07分，Phio Pharmaceuticals Corp.股票出现异动，股价快速下跌8.41%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.44%。其相关个股中，Silo Pharma, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Conduit Pharmaceuticals Inc.涨幅较大，Silo Pharma, Inc.、Scisparc Ltd.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为1833.40%、1065.65%、97.44%，振幅较大的相关个股有Silo Pharma, Inc.、Scisparc Ltd.、Conduit Pharmaceuticals Inc.，振幅分别为43.93%、40.48%、39.04%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162207429681d34f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162207429681d34f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2451762845","title":"Phio Pharmaceuticals Corp.盘中异动 早盘急速拉升6.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451762845","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451762845?lang=zh_cn&edition=full","pubTime":"2024-07-15 21:48","pubTimestamp":1721051322,"startTime":"0","endTime":"0","summary":"北京时间2024年07月15日21时48分，Phio Pharmaceuticals Corp.股票出现异动，股价大幅上涨6.14%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.59%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715214842af926579&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715214842af926579&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2450350539","title":"Phio Pharmaceuticals Corp.盘中异动 早盘股价大跌5.90%报5.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450350539","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450350539?lang=zh_cn&edition=full","pubTime":"2024-07-12 22:03","pubTimestamp":1720793019,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日22时03分，Phio Pharmaceuticals Corp.股票出现异动，股价急速跳水5.90%。截至发稿，该股报5.50美元/股，成交量4614股，换手率0.90%，振幅1.71%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为1.34%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712220339941f6ab0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712220339941f6ab0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2450369396","title":"Phio Pharmaceuticals Corp.盘中异动 股价大跌5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450369396","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450369396?lang=zh_cn&edition=full","pubTime":"2024-07-11 22:05","pubTimestamp":1720706701,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日22时05分，Phio Pharmaceuticals Corp.股票出现波动，股价急速下跌5.34%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.78%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711220501af91deec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711220501af91deec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2450843886","title":"Phio Pharmaceuticals Corp.盘中异动 股价大涨7.37%报5.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450843886","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450843886?lang=zh_cn&edition=full","pubTime":"2024-07-11 00:41","pubTimestamp":1720629669,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日00时41分，Phio Pharmaceuticals Corp.股票出现异动，股价快速上涨7.37%。截至发稿，该股报5.97美元/股，成交量1.0319万股，换手率2.02%，振幅4.55%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为1.11%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711004109941f5deb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711004109941f5deb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2450237300","title":"Phio Pharmaceuticals Corp.盘中异动 大幅跳水5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450237300","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450237300?lang=zh_cn&edition=full","pubTime":"2024-07-09 21:55","pubTimestamp":1720533344,"startTime":"0","endTime":"0","summary":"北京时间2024年07月09日21时55分，Phio Pharmaceuticals Corp.股票出现异动，股价急速下挫5.42%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为0.59%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Uniqure N.V.、Longeveron Inc.涨幅较大，Anew Medical, Inc.、60 Degrees Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为118.51%、86.43%、83.67%，振幅较大的相关个股有Longeveron Inc.、Anew Medical Inc C/Wts 21/06/2029 、Uniqure N.V.，振幅分别为36.67%、33.17%、32.64%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407092155449681b296&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407092155449681b296&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2449703406","title":"Phio Pharmaceuticals Corp.盘中异动 股价大跌5.14%报4.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449703406","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449703406?lang=zh_cn&edition=full","pubTime":"2024-07-08 21:31","pubTimestamp":1720445512,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日21时31分，Phio Pharmaceuticals Corp.股票出现波动，股价大幅下挫5.14%。截至发稿，该股报4.98美元/股，成交量3043股，换手率0.60%，振幅1.14%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.16%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708213152af9115c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708213152af9115c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2449987892","title":"BUZZ-Phio Pharma 因终止与 Triton Funds 的股份购买协议而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2449987892","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449987892?lang=zh_cn&edition=full","pubTime":"2024-07-05 21:57","pubTimestamp":1720187848,"startTime":"0","endTime":"0","summary":"    7月5日 - ** 生物技术公司Phio Pharmaceuticals   股价下跌8.8%至4.77美元 ** 该公司在一份文件中称，它于7月3日终止了与基金经理Triton Funds LP的股票购买协议，Triton本可以购买该公司18.8%的股票。** PHIO 表示，董事会认为 \"终止购买协议并寻求其他融资方式 \"符合公司及其股东的最佳利益。** 公司于 2024 年 5 月 16 日与 Triton Funds 签订购买协议，以每股 6.48 美元的价格出售最多 95,833 股股票，价值约 62.1 万美元。** 包括盘中走势在内，该股今年累计下跌 91.5","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHIO","BUZZ","BK4139"],"gpt_icon":0},{"id":"2449298675","title":"Phio Pharmaceuticals Corp.盘中异动 急速跳水9.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449298675","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449298675?lang=zh_cn&edition=full","pubTime":"2024-07-05 21:32","pubTimestamp":1720186346,"startTime":"0","endTime":"0","summary":"北京时间2024年07月05日21时32分，Phio Pharmaceuticals Corp.股票出现波动，股价急速下跌9.89%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.58%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705213227aef82ce5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705213227aef82ce5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2448660271","title":"Phio Pharmaceuticals Corp.盘中异动 临近午盘急速下跌9.36%报0.609美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448660271","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448660271?lang=zh_cn&edition=full","pubTime":"2024-07-02 23:46","pubTimestamp":1719935162,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日23时46分，Phio Pharmaceuticals Corp.股票出现波动，股价快速下跌9.36%。截至发稿，该股报0.609美元/股，成交量5.2593万股，换手率1.15%，振幅15.66%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为0.51%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407022346029ef55f1b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407022346029ef55f1b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2446540305","title":"Phio Pharmaceuticals Corp.盘中异动 大幅下跌7.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446540305","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446540305?lang=zh_cn&edition=full","pubTime":"2024-06-27 23:22","pubTimestamp":1719501747,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日23时22分，Phio Pharmaceuticals Corp.股票出现异动，股价急速下挫7.03%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为0.31%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627232228af8f8cf7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627232228af8f8cf7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2446991273","title":"Phio Pharmaceuticals Corp.盘中异动 股价大跌5.00%报0.690美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446991273","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446991273?lang=zh_cn&edition=full","pubTime":"2024-06-26 21:54","pubTimestamp":1719410053,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日21时54分，Phio Pharmaceuticals Corp.股票出现异动，股价急速下挫5.00%。截至发稿，该股报0.690美元/股，成交量5964股，换手率0.13%，振幅2.40%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为1.21%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626215413941f1689&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626215413941f1689&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2446003710","title":"Phio Pharmaceuticals Corp.盘中异动 大幅拉升6.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446003710","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446003710?lang=zh_cn&edition=full","pubTime":"2024-06-25 01:39","pubTimestamp":1719250793,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日01时39分，Phio Pharmaceuticals Corp.股票出现异动，股价大幅拉升6.03%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为1.91%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625013953941f09dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625013953941f09dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2443606599","title":"Phio Pharmaceuticals Corp.盘中异动 下午盘股价大跌6.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443606599","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443606599?lang=zh_cn&edition=full","pubTime":"2024-06-13 03:29","pubTimestamp":1718220541,"startTime":"0","endTime":"0","summary":"北京时间2024年06月13日03时29分，Phio Pharmaceuticals Corp.股票出现异动，股价大幅下跌6.67%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.65%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。消息层面，截至03时29分，《Phio Pharmaceuticals董事增持1,000股普通股股份，价值约750美元》资讯为影响Phio Pharmaceuticals Corp.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406130329019f360ad6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406130329019f360ad6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","LGVN","BK4139"],"gpt_icon":0},{"id":"2441971066","title":"Phio Pharmaceuticals Corp.盘中异动 股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441971066","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441971066?lang=zh_cn&edition=full","pubTime":"2024-06-06 21:31","pubTimestamp":1717680670,"startTime":"0","endTime":"0","summary":"北京时间2024年06月06日21时31分，Phio Pharmaceuticals Corp.股票出现波动，股价大幅上涨5.01%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为0.01%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406062131109f20ce3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406062131109f20ce3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2440231835","title":"Phio Pharmaceuticals Corp.盘中异动 股价大跌5.98%报0.732美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2440231835","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440231835?lang=zh_cn&edition=full","pubTime":"2024-06-04 22:34","pubTimestamp":1717511653,"startTime":"0","endTime":"0","summary":"北京时间2024年06月04日22时34分，Phio Pharmaceuticals Corp.股票出现波动，股价急速跳水5.98%。截至发稿，该股报0.732美元/股，成交量3702股，换手率0.08%，振幅3.85%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为0.59%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604223413aef35709&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604223413aef35709&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANNX","PHIO"],"gpt_icon":0},{"id":"2440995094","title":"Phio Pharmaceuticals Corp.盘中异动 早盘急速拉升6.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440995094","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440995094?lang=zh_cn&edition=full","pubTime":"2024-06-03 22:15","pubTimestamp":1717424147,"startTime":"0","endTime":"0","summary":"北京时间2024年06月03日22时15分，Phio Pharmaceuticals Corp.股票出现波动，股价大幅拉升6.85%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为1.46%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406032215479681186a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406032215479681186a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2438309454","title":"Phio Pharmaceuticals Corp.盘中异动 早盘股价大跌5.92%报0.720美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2438309454","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438309454?lang=zh_cn&edition=full","pubTime":"2024-05-28 23:20","pubTimestamp":1716909619,"startTime":"0","endTime":"0","summary":"北京时间2024年05月28日23时20分，Phio Pharmaceuticals Corp.股票出现波动，股价大幅下跌5.92%。截至发稿，该股报0.720美元/股，成交量6.1875万股，换手率1.35%，振幅7.84%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体跌幅为1.53%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405282320239681045b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405282320239681045b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2435465309","title":"Phio Pharmaceuticals Corp.盘中异动 快速下跌7.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435465309","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435465309?lang=zh_cn&edition=full","pubTime":"2024-05-14 02:27","pubTimestamp":1715624855,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日02时27分，Phio Pharmaceuticals Corp.股票出现异动，股价急速下挫7.57%。Phio Pharmaceuticals Corp.股票所在的生物技术行业中，整体涨幅为1.28%。Phio Pharmaceuticals Corp.公司简介：Phio Pharmaceuticals Corp是一家临床阶段的生物技术公司，其专有的 INTASYL 自传递 RNAi 技术平台旨在使免疫细胞更有效地杀死肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051402273587e87938&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051402273587e87938&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHIO"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.phiopharma.com","stockEarnings":[{"period":"1week","weight":-0.2368},{"period":"1month","weight":-0.2841},{"period":"3month","weight":-0.1783},{"period":"6month","weight":-0.2236},{"period":"1year","weight":-0.8063},{"period":"ytd","weight":-0.3104}],"compareEarnings":[{"period":"1week","weight":-0.0078},{"period":"1month","weight":0.018},{"period":"3month","weight":0.115},{"period":"6month","weight":0.1544},{"period":"1year","weight":0.2262},{"period":"ytd","weight":0.1717}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Phio Pharmaceuticals Corp.是一家生物技术公司，基于公司专有的新一代核糖核酸干扰(RNAi)平台专注于发现、开发和商业化创新疗法。由于这些疗法得“沉默”能力,或者说是其下调能力,病态情况下的特定基因可以被分析的更为清楚，所以基于RNAi平台的疗法更有说服力的。2011年9月8日之前,该公司的业务由其非操作部门Galena Biopharma公司（该公司的前母公司）来完成。公司成立于特拉华州，作为Galena 的全资子公司。2011年9月8日开始，其计划并准备与Galena脱离。2012年4月27日这一计划得以完成。至此之后,公司作为一个独立的上市公司运营。","yearOnYearQuotes":[{"month":1,"riseRate":0.3,"avgChangeRate":-0.062312},{"month":2,"riseRate":0.4,"avgChangeRate":-0.033019},{"month":3,"riseRate":0.454545,"avgChangeRate":-0.080586},{"month":4,"riseRate":0.272727,"avgChangeRate":-0.121062},{"month":5,"riseRate":0.272727,"avgChangeRate":-0.038426},{"month":6,"riseRate":0.454545,"avgChangeRate":-0.020605},{"month":7,"riseRate":0.363636,"avgChangeRate":-0.080956},{"month":8,"riseRate":0.3,"avgChangeRate":-0.018205},{"month":9,"riseRate":0,"avgChangeRate":-0.17163},{"month":10,"riseRate":0.3,"avgChangeRate":-0.130613},{"month":11,"riseRate":0.4,"avgChangeRate":-0.060945},{"month":12,"riseRate":0.2,"avgChangeRate":-0.125431}],"exchange":"NASDAQ","name":"Phio Pharmaceuticals","nameEN":"Phio Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Phio Pharmaceuticals(PHIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Phio Pharmaceuticals(PHIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Phio Pharmaceuticals,PHIO,Phio Pharmaceuticals股票,Phio Pharmaceuticals股票老虎,Phio Pharmaceuticals股票老虎国际,Phio Pharmaceuticals行情,Phio Pharmaceuticals股票行情,Phio Pharmaceuticals股价,Phio Pharmaceuticals股市,Phio Pharmaceuticals股票价格,Phio Pharmaceuticals股票交易,Phio Pharmaceuticals股票购买,Phio Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Phio Pharmaceuticals(PHIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Phio Pharmaceuticals(PHIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}